Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2000

View Archived Issues

Pharmacokinetics of SAM-486A useful in predicting toxicity

Positive preclinical results reported for Meditech's MTCH-24

Aurora Biosciences and Organon sign assay development agreement

Expired air from asthmatic subjects has unusually low pH

Initial clinical results with HE-2000 indicate immune system switch in HIV

Arisostatins identified as new tetrocarcin antibiotics with antibacterial/antitumor activity

Pharming highlights product development efforts for 1999

Clinical progress at Amylin during 1999 discussed

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

Phytopharm invests in Indian manufacturing plant

Glaxo Wellcome obtains nonexclusive HCV license from Chiron

Company Profile: Novuspharma

New 5-HT4 antagonists preferably useful for urinary tract disorders

Antifungal lactone isolated from a fungus at Pfizer

SB's new dopamine D3 receptor modulators particularly useful for schizophrenia

Broad-spectrum carbapenems reported by Wyeth Lederle Japan

BioInvent to produce therapeutic antibody for Wilex

FDA approves Actonel for osteoporosis prevention and treatment

Flocor study results presented at sickle cell conference

BioTime begins clinical testing of new blood plasma volume expander

Major European launch announced for Sonata

Antihistamines reported useful by Schering-Plough for Rx of sinusitis and otitis media

Azabicyclic compounds as modulators of cell adhesion

Florida A&M's novel nonsteroidal antiinflammatory agents inhibit NO production

Preclinical and clinical efficacy of RWJ-270201 characterized at recent congress

FDA approves first oxazolidinone antimicrobial drug

PEG-hirudin superior to unfractionated heparin for short-term reduction of silent ischemia

Health Canada approves Aggrenox for prevention of recurrent stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...